The tech world often shows its best side in times of crisis. NDA’s new series showcases those companies and the solutions that they are building.
During a pandemic, healthcare professionals’ access to the latest clinical evidence is crucial to inform point of care decision making and evolving healthcare policy. The Cochrane COVID-19 Study Register is a precisely scoped, authoritative source of the latest clinical evidence on COVID-19 from around the world that does exactly that.
It is being used to locate relevant, reliable clinical evidence about specific healthcare questions from the latest Randomised Controlled Trial (RCT), observational, modelling and other studies to support the fight against Covid-19.
It is built on a scalable knowledge graph platform architecture, and its structure and flexibility means that new use cases can be delivered rapidly and efficiently.
Cochrane is a global not-for-profit organisation whose core mission is to put evidence at the heart of health decision-making all over the world. The register was built by Data Language, the data science consultancy and solution provider and one of Cochrane’s long term technology partners.
Data Language CTO Julian Everett told us: “This crucial, trusted resource is essential at a time when the evidence base is developing rapidly, in order to ensure clinical decisions and healthcare policy can continually be informed by the most reliable and up-to-date information.
Send your tech for good solutions to newdigitalage@bluestripemedia.co.uk
